Back to Search Start Over

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.

Authors :
Meyers, G.
Hamadani, M.
Martens, M.
Ali, H.
Chevallier, P.
Choe, H.
Harris, A.C.
Holler, E.
Hooren, E. van
Klaassen, W.
Leifer, E.
Oosterhout, Y. van
Perez, L.
Pusic, I.
Stelljes, M.
Velden, W.J.F.M. van der
Ammatuna, E.
Beauvais, D.
Cornillon, J.
Maziarz, R.T.
Schetelig, J.
Romeril, J.
MacMillan, M.L.
Levine, J.E.
Socié, G.
Meyers, G.
Hamadani, M.
Martens, M.
Ali, H.
Chevallier, P.
Choe, H.
Harris, A.C.
Holler, E.
Hooren, E. van
Klaassen, W.
Leifer, E.
Oosterhout, Y. van
Perez, L.
Pusic, I.
Stelljes, M.
Velden, W.J.F.M. van der
Ammatuna, E.
Beauvais, D.
Cornillon, J.
Maziarz, R.T.
Schetelig, J.
Romeril, J.
MacMillan, M.L.
Levine, J.E.
Socié, G.
Source :
Bone Marrow Transplantation, 58, 12, pp. 1416-1418
Publication Year :
2023

Abstract

Contains fulltext : 299881.pdf (Publisher’s version ) (Closed access)<br />01 december 2023

Details

Database :
OAIster
Journal :
Bone Marrow Transplantation, 58, 12, pp. 1416-1418
Publication Type :
Electronic Resource
Accession number :
edsoai.on1414635313
Document Type :
Electronic Resource

Tools

Authors Abstract Subjects Details